Pharma/Biotech – USA, Europe, Asia and ROW Regulatory News – June 2024
USA
FDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test
The U.S. Food and Drug Administration granted marketing authorization to Cepheid for the Xpert HCV test and GeneXpert Xpress...
Biotech Updates, Clinical Trials, Drug Safety, EMA, FDA, Global Health, Healthcare Regulations, Medical Devices, Pharma News, Regulatory News
